These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9361690)

  • 1. Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression.
    Goñi MJ; Monreal M; Goñi F; Sopena M; Gil MJ; Moncada E; Salvador J
    Metabolism; 1997 Nov; 46(11):1305-11. PubMed ID: 9361690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
    J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes.
    Aman J; Kroon M; Karlsson I; Jones I; Hagenäs L
    Acta Paediatr; 1996 Jan; 85(1):31-7. PubMed ID: 8834976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.
    Díez JJ; Iglesias P; Aguilera A; Bajo MA; Selgas R
    Nephrol Dial Transplant; 1999 Jul; 14(7):1704-9. PubMed ID: 10435880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone.
    Arce VM; Cella SG; Locatelli V; Müller EE
    Neuroendocrinology; 1991 May; 53(5):467-72. PubMed ID: 1908062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
    Díez JJ; Iglesias P; Selgas R; Bajo MA; Aguilera A
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):587-93. PubMed ID: 11106919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
    Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus.
    Krassowski J; Szulc P; Makowska A; Godziejewska M; Jeske W; Zgliczynski S
    Diabetes Res Clin Pract; 1993 Mar; 19(3):211-6. PubMed ID: 8319519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics.
    Bevan JS; Ara J; Page MD; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):85-91. PubMed ID: 1889143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.
    Halldin MU; Brismar K; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):735-43. PubMed ID: 12460323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early morning hyperglycemia in insulin-dependent diabetes: acute and sustained effects of cholinergic blockade.
    Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
    J Clin Endocrinol Metab; 1989 Aug; 69(2):390-5. PubMed ID: 2666430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients.
    Alvarez P; Isidro L; Peinó R; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):431-6. PubMed ID: 14510904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine].
    Krassowski J; Rogala H; Jeske W; Zgliczyński S
    Pol Arch Med Wewn; 1992 Jul; 88(1):25-9. PubMed ID: 1454656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic modulation of spontaneous hypothalamic-pituitary-adrenal activity and its circadian variation in man.
    Llorente I; Lizcano F; Alvarez R; Diez N; Sopena M; Gil MJ; Salvador J
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2902-7. PubMed ID: 8768849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.
    Moorkens G; Berwaerts J; Wynants H; Abs R
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):99-106. PubMed ID: 10931086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Martina V; Pontiroli AE; Tagliabue M; Calderara A; Maccario M; Pacchioni M; Bertaina S; Bruno G; Pozza G; Camanni F
    Horm Metab Res; 1994 Mar; 26(3):148-51. PubMed ID: 8005563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.